RenovaCare (RCAR) 10-Q 14 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 14, 2013
Document And Entity Information	'	'
Entity Registrant Name	'Janus Resources, Inc.	'
Entity Central Index Key	'0001016708	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	63,075,122
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2013	'

CONSOLIDATED_BALANCE_SHEETS_Un

CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets	'	'
Cash and cash equivalents	$236,099	$513,595
Prepaid expenses	1,504	7,562
Current assets of discontinued operations	'	800
Total current assets	237,603	521,957
Long-term assets of discontinued operations	'	24,127
Mineral properties	519,750	519,750
Intangible Assets	152,854	'
Total assets	910,207	1,065,834
Current liabilities	'	'
Accounts payable and accrued liabilities	83,361	17,973
Accounts payable - related parties	74,562	9,638
Current liabilities of discontinued operations	'	12,932
Total current liabilities	157,923	40,543
Long-term liabilities of discontinued operations	'	57,532
Total liabilities	157,923	98,075
STOCKHOLDERS' EQUITY	'	'
Preferred stock: $0.0001 par value: Authorized: 10,000,000 shares, Issued and outstanding: nil	'	'
Common stock: $0.00001 par value: Authorized: 200,000,000 shares, Issued and outstanding: 63,075,122 shares (2012: 63,075,122)	631	631
Additional paid-in capital	5,526,526	5,462,236
Accumulated deficit	-4,456,504	-4,491,004
Accumulated deficit since development stage	-314,265	'
Accumulated other comprehensive loss	-4,104	-4,104
Total stockholders' equity	752,284	967,759
Total liabilities and stockholders' equity	$910,207	$1,065,834

CONSOLIDATED_BALANCE_SHEETS_Un1

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
STOCKHOLDERS' EQUITY	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, Authorized	10,000,000	10,000,000
Preferred stock, shares Issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, Authorized	200,000,000	200,000,000
Common stock, shares Issued	63,075,122	63,075,122
Common stock, shares outstanding	63,075,122	63,075,122

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		7 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012
Consolidated Statements Of Operations	'	'	'	'	'
Revenue	'	'	'	'	'
Expenses	'	'	'	'	'
Exploration expenses	'	'	'	'	11,284
General and administrative expenses	184,862	38,112	314,265	329,103	188,054
Total operating expenses	184,862	38,112	314,265	329,103	199,338
Net loss from continuing operations	-184,862	-38,112	-314,265	-329,103	-199,338
Discontinued operations	'	'	'	'	'
Income / (loss) from discontinued oil and gas operations	'	-424	'	'	-389
Gain on disposal of oil and gas operations	'	'	'	-49,338	'
Gain (loss) on discontinued operations	'	-424	'	49,338	-389
Net loss	($184,862)	($38,536)	($314,265)	($279,765)	($199,727)
Earnings per share - basic and diluted	'	'	'	'	'
Loss per common share continuing operations	$0	$0	'	($0.01)	$0
Income (loss) per common share discontinued operations	'	$0	'	$0	$0
Loss per common share	$0	$0	'	($0.01)	$0
Weighted average shares outstanding	63,075,122	63,075,122	'	63,075,122	63,075,122

CONSOLIDATED_STATEMENT_COMPREH

CONSOLIDATED STATEMENT COMPREHENSIVE LOSS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Consolidated Statement Comprehensive Loss	'	'	'	'
Net loss	($184,862)	($38,536)	($279,765)	($199,727)
Other comprehensive loss	'	'	'	'
Foreign currency translation adjustments	'	'	'	-904
Total comprehensive loss	($184,862)	($38,536)	($279,765)	($200,631)

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited0 (USD $)	Common Stock	Additional Paid-In Capital	Accumulated deficit	Cumulative since Feb 20, 2013 (Inception of Development Stage) Accumulated deficit	Accumulated other comprehensive (loss)	Total
Beginning Balance, Amount at Dec. 31, 2011	$631	$5,462,236	($4,247,045)	'	($4,104)	$1,211,718
Beginning Balance, Shares at Dec. 31, 2011	63,075,122	'	'	'	'	'
Net income (loss)	'	'	-243,959	'	'	-243,959
Ending Balance, Amount at Dec. 31, 2012	631	5,462,236	-4,491,004	'	-4,104	967,759
Ending Balance, Shares at Dec. 31, 2012	63,075,122	'	'	'	'	'
Series A Warrant	'	54,668	'	'	'	54,668
Stock based compensation - options	'	9,622	'	'	'	9,622
Net income (loss)	'	'	34,500	-314,265	'	-279,765
Ending Balance, Amount at Sep. 30, 2013	$631	$5,526,526	($4,456,504)	($314,265)	($4,104)	$752,284
Ending Balance, Shares at Sep. 30, 2013	63,075,122	'	'	'	'	'

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	7 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities	'	'	'
Net loss	($314,265)	($279,765)	($199,727)
Adjustments to reconcile net loss to net cash flows from operating activities:	'	'	'
Stock based compensation expense	9,622	9,622	'
Stock based consulting expense	54,668	54,668	'
Impairment and depreciation	'	'	1,527
Accretion of asset retirement obligation	'	'	2,216
Gain on disposal of oil and gas properties	'	-49,338	'
Changes in operating assets and liabilities:	'	'	'
Decrease (increase) in receivables	801	800	14,514
Decrease (increase) in prepaid expenses	3,541	6,058	-9,220
(Decrease) increase in accounts payable and accrued expenses	84,451	83,313	-15,317
Net cash flows from operating activities	-161,182	-174,642	-206,007
Cash flows from investing activities:	'	'	'
Acquisition of oil and gas properties	'	'	-2,754
Proceeds from disposal of oil and gas properties	3,000	3,000	'
Acquisition of intellectual property	-105,854	-105,854	'
Net cash flows from investing activities	-102,854	-102,854	-2,754
Effect of exchange rate changes on cash and cash equivalents	-9	'	-904
Decrease in cash and cash equivalents	-264,045	-277,496	-209,665
Cash and cash equivalents, beginning of period	500,144	513,595	787,771
Cash and cash equivalents, end of period	236,099	236,099	578,106
Supplemental disclosure of cash flow information:	'	'	'
Interest paid in cash	'	'	'
Income tax paid in cash	'	'	'
Non-cash Investing and Financing Activities	'	'	'
Acquisition of intellectual property with accounts payable	'	$47,000	'

Organization_Nature_and_Contin

Organization, Nature and Continuance of Operations	9 Months Ended
	Sep. 30, 2013
Organization Nature And Continuance Of Operations	'
Note 1. Organization, Nature and Continuance of Operations	'
	Janus Resources, Inc., together with its wholly owned subsidiaries (the “Company”), is in the business of developing and, if warranted, commercializing organ regeneration technologies. The Company was previously involved in the exploration and development of both mineral exploration properties and oil and gas properties. The Company sold its oil and gas properties on February 18 and 19, 2013. Effective February 20, 2013, the Company became a development stage company.
	On July 29, 2013, the Company’s Board approved the disposition of its Fostung tungsten mineral properties located in Canada (the “Fostung Property”). Management is evaluating alternatives for the disposition of these mineral exploration assets. The properties have not yet been disposed of by sale and therefore are classified as assets held and used during the periods presented.
	On July 12, 2013, the Company, together with its wholly owned subsidiary, Janus Acquisition Corp., a Nevada corporation (“JAC”), entered into an asset purchase agreement with Dr. Jörg Gerlach, MD, PhD, pursuant to which JAC purchased all of Dr. Gerlach’s rights, title and interest to an organ regeneration technology (collectively, the “Regeneration Technology”). The Company plans to further the development of the Regeneration Technology and, if commercially viable, bring the product to market for use in a variety of applications.
	The Company has recently incurred net operating losses and operating cash flow deficits. The Company’s total accumulated deficit is $4.8 million as of September 30, 2013. The Company does not currently generate revenues and will continue to incur losses from operations and operating cash flow deficits in the future. Management believes that the Company’s cash and cash equivalent balances, anticipated cash flows from operations and other external sources of capital will be sufficient to meet our cash requirements for the next six months. The future of the Company after March 2014 will depend in large part on its ability to successfully raise capital from external sources to fund operations.

Significant_Accounting_Policie

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2013
Significant Accounting Policies	'
Note 2. Significant Accounting Policies	'
	Basis of Presentation and Principles of Accounting
	As the Company is devoting substantially all of its efforts to establishing a new business, and while planned principal operations have commenced, there has been no revenue generated from sales, license fees or royalties, and as such, the Company is considered a development stage company. Accordingly, the Company’s consolidated financial statements are presented in accordance with authoritative accounting guidance related to a development stage enterprise.
	The interim consolidated financial statements included herein have been prepared by the Company, without audit, in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) pursuant to Part 210 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations, although the Company believes that the disclosures included are adequate to make the information presented not misleading.
	In management’s opinion, the unaudited consolidated financial statements contained herein reflect all adjustments, consisting solely of normal recurring items, which are necessary for the fair presentation of our financial position, results of operations, and cash flows on a basis consistent with that of our prior audited consolidated financial statements. The Company has evaluated information about subsequent events that became available to us through the date the financial statements were issued. This information relates to events, transactions or changes in circumstances that would require us to adjust the amounts reported in the financial statements or to disclose information about those events, transactions or changes in circumstances. However, the results of operations for interim periods may not be indicative of results to be expected for the full fiscal year. Therefore, these financial statements should be read in conjunction with the Company’s audited consolidated financial statements including the notes thereto for the year ended December 31, 2012, which may be found under the Company’s profile on EDGAR.
	The accounting policies followed by the Company are set out in Note 2 to the audited consolidated financial statements for the year ended December 31, 2012 and have been consistently followed in the preparation of these interim consolidated financial statements.
	Principles of Consolidation
	These interim consolidated financial statements have been prepared in accordance with US GAAP and include the accounts of the Company and its wholly owned subsidiaries, JAC and Fostung Resources, Limited (“Fostung”). All significant intercompany transactions and balances have been eliminated. JAC was incorporated under the laws of the State of Nevada on June 12, 2013. Fostung was incorporated on May 10, 2011, in Ontario Canada.
	Applicable Accounting Guidance
	Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative non-governmental US GAAP as found in the Financial Accounting Standards Board’s Accounting Standards Codification.
	Accounting Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined by future events, may differ from these estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents at September 30, 2013 and December 31, 2012.
	Research and Development Costs
	The Company intends to outsource its research and development efforts and expense related costs as incurred, including the cost of manufacturing product for testing, licensing fees and costs associated with planning and conducting clinical trials. The value ascribed to patents and other intellectual property acquired will be capitalized as it relates to particular research and development projects that may have alternative future uses.
	Stock Options
	The Company measures all stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The Company uses the Black-Scholes pricing model to determine the fair value of stock-based compensation awards on the date of grant. The Black-Scholes pricing model requires management to make assumptions regarding option lives, expected volatility, and risk free interest rates.
	Income Taxes
	The Company recognizes income taxes on an accrual basis based on tax positions taken, or expected to be taken, in our tax returns.  A tax position is defined as a position in a previously filed tax return or a position expected to be taken in future tax filing that is reflected in measuring current or deferred income tax assets and liabilities.  Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities.  Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our financial statements or tax returns.  A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized.  No provision for income taxes was recorded during the periods presented because the Company had a net taxable loss.  Should they occur, our policy is to classify interest and penalties related to tax positions as interest expense.  Since our inception, no such interest or penalties have been incurred.
	Discontinued Operations
	The assets and financial results of the Company’s oil and gas properties are being reported as discontinued operations as a result of the sale thereof in February 2013. Certain amounts reported in the prior periods presented have been reclassified to conform to the current period financial statement presentation. These reclassifications have no effect on previously reported net income (loss). See “Note 3. Discontinued Oil and Gas Operations” for a summary of the amounts reclassified for the periods presented herein.
	Earnings (Loss) Per Share
	The Company presents both basic and diluted earnings per share (“EPS”) amounts. Basic EPS is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period presented. Diluted EPS amounts are based upon the weighted average number of common and common equivalent shares outstanding during the period presented. Potentially dilutive shares of common stock consisted of warrants to purchase shares of common stock (1,200,000 shares for 2013 and nil shares for 2012) and options to purchase shares of common stock (40,000 shares for 2013 and nil shares for 2012).  During the periods presented, potentially dilutive shares of common stock were not included in the computation of dilutive loss per share as to do so would be anti-dilutive.
	Foreign Currency Translation
	Transactions and account balances originally stated in currencies other than the U.S. dollar have been translated into U.S. dollars as follows:
	·	Revenue and expense items are translated at the average exchange rate for the period in which they are incurred.
	·	Non-monetary assets and liabilities at the rate of exchange in effect on the dates the assets were acquired or the liabilities were incurred.
	·	Monetary assets and liabilities at the exchange rate at the balance sheet date.
	Exchange gains and losses are recorded in operations in the period in which they occur, except for exchange gains and losses related to translation of monetary assets and liabilities associated with mineral properties, which are deferred and included in reported value of the mineral properties.
	Comprehensive Income (Loss)
	Comprehensive loss is comprised of net loss and foreign currency translation adjustments for the periods presented.
	Related Party Transactions
	A related party is generally defined as (i) any person who holds 10% or more of the Company’s securities and their immediate families; (ii) the Company’s management; (iii) someone who directly or indirectly controls, is controlled by or is under common control with the Company; or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See “Note 8. Related Party Transactions,” for further discussion.

Discontinued_Oil_and_Gas_Opera

Discontinued Oil and Gas Operations	9 Months Ended
	Sep. 30, 2013
Discontinued Oil And Gas Operations	'
Note 3. Discontinued Oil and Gas Operations	'
	On February 18, 2013, we completed the sale of our working interest in the Onnie Ray #1, Haile #1, Pearce #1 and Stahl #1 oil wells. We entered into an Assignment Agreement with Leexus Oil LLC, the wells operator, whereby the Company assigned its right, title and interest in the oil, gas and mineral leases and the oil and gas wells. Consideration for the assignment was the assumption of all outstanding liabilities and assumption of all future payments for any and all work performed on the wells.
	On February 19, 2013, we completed the sale of our working interest in the Cooke #6 well. We entered into an Assignment Agreement with Millennium Petro-Physics, the well operator, whereby we assigned the right, title and interest in the oil, gas and mineral leases and the oil and gas wells. Consideration for the assignment was $3,000 cash.
	The carrying amount of the oil and gas properties was $24,127 on the date of disposal. The related asset retirement obligation amounted to $57,532 and liabilities assumed amounted to $12,932. Including the $3,000 cash received, the Company recognized a gain of $49,338 in the nine month period ended September 30, 2013, as a result of the disposal.
	The Company’s revenue, reported in discontinued operations, for the three and nine months ended September 30, 2013 were $0 and $0, respectively, and for the three and nine months ended September 30, 2012 were $7,034 and $16,549, respectively. The Company’s net income (loss) reported in discontinued operations for the three and nine months ended September 30, 2013 was $0 and $49,338, respectively, and for the three and nine months ended September 30, 2012 was $(424) and $(389), respectively. The Company has not recognized any revenue nor incurred expenses with respect to its previously owned oil and gas properties since the sale of its oil and gas properties, and will not recognize any continuing cash flows with respect to these properties in the future.
	Assets and liabilities of discontinued operations in the accompanying balance sheets consist of the following:
		30-Sep-13		31-Dec-12
	Assets
	Unproven Properties	$	-	$	537,501
	Depriciation and impairment		-		(513,374	)
	Oil and gas properties, net	$	-	$	24,127
	Liabilities
	Accounts payable	$	-	$	(12,932	)
	Asset retirement obligation		-		(57,532	)
		$	-	$	(70,464	)

Mineral_Properties_and_Explora

Mineral Properties and Exploration Expenses	9 Months Ended
	Sep. 30, 2013
Mineral Properties And Exploration Expenses	'
Note 4. Mineral Properties and Exploration Expenses	'
	Foster Township, Sudbury, Ontario, Canada - Fostung Tungsten Property (the “Fostung Property”)
	(a)	On June 8, 2011, pursuant to an asset purchase agreement, the Company paid CAD $500,000 in cash for the acquisition of EMC Metals Corp.’s 100% leasehold interest in two mining leases known as the Fostung Property. The Fostung Property consists of two contiguous claim blocks of 30 claims totaling 485 hectors. The nine claims covered by Mining Lease 108592 expire on October 31, 2031. The twenty-one claims covered by Mining Lease 108847 have been extended by the Ministry of Northern Development, Mines and Forestry (“MNDMF”) through March 31, 2032. The Fostung Property is located in Foster Township, Sudbury Mining Division, Ontario, Canada. It is approximately 8 kilometers southeast of the town of Espanola and 70 kilometers west-southwest of the town of Sudbury. An excellent all-weather gravel road extends from Espanola, crossing the property and providing access to the west bay of Lake Panache.
		A production bonus in the amount of CAD $500,000 is payable to Breakwater Resources Ltd. by the Company within thirty business days following the commencement of commercial production from the property. A 1% net smelter return royalty on the property is also payable to Breakwater Resources Ltd. by the Company. No capitalized costs have been amortized as of September 30, 2013. The Company did not incur any impairment of these capitalized costs through September 30, 2013.
	(b)	The Fostung Property also consists of four unpatented mining claims, located in Foster Township in the Sudbury Mining Division, Ontario, Canada, comprised of 26 claim units which were recorded in the name of Fostung Resources Ltd. on June 7, 2011. Two of the four mining claim blocks consisting of two contiguous claims are located to the north east of the structural trend in the two contiguous claim blocks of 30 claims referred to in (a) above. Two of the four mining claim blocks consisting of two contiguous claims are located to the south west of the structural trend in the two contiguous claim blocks of 30 claims referred to in (a) above. Leases related to each of the four claims expired on June 7, 2013. On July 18, 2013, we filed an application for relief from forfeiture with the MNDMF to renew the leases.  No response has been received as of the date of this report.  The aggregate amount required to be expended in order to renew the four claims is CAD $10,400.
		On July 29, 2013, the Company’s Board of Directors approved the disposition of the Fostung Property. Management is evaluating alternatives for the disposition of these mineral exploration assets.

Intangible_Assets_Intellectual

Intangible Assets - Intellectual Property	9 Months Ended
	Sep. 30, 2013
Intangible Assets - Intellectual Property	'
Note 5. Intangible Assets - Intellectual Property	'
	On July 12, 2013, the Company, together with its wholly owned subsidiary, JAC, entered into an asset purchase agreement with Dr. Jörg Gerlach, MD, PhD, pursuant to which JAC purchased all of Dr. Gerlach’s rights, title and interest in the Regeneration Technology. The Company plans to further the development of the Regeneration Technology and, if commercially viable, bring the product to market. Pursuant to the terms of the Asset Purchase Agreement, upon the closing of the transaction, the Company paid Dr. Gerlach $100,002 and issued to Dr. Gerlach a Series A Stock Purchase Warrant (the “Series A Warrant”) entitling him to purchase 1,200,000 shares (each a “Warrant Share”) of the Company’s common stock, subject to vesting milestones through July 11, 2019, at an exercise price of $0.35 per share.  Acquisition related costs amounted to $52,852 and were capitalized together with the cash payment.
	The Series A Warrant was issued in exchange for services to be rendered in the future by Dr. Gerlach.  An additional agreed upon cash sum will be paid to Dr. Gerlach upon the Company attaining certain milestones related to the Regeneration Technology. The value of the Series A Warrant will be recognized as consulting expenses by the Company over the vesting term of the underlying warrant, subject to Dr. Gerlach providing ongoing consulting services to the Company with respect to the Regeneration Technology. As such, the measurement date for accounting purposes will be the date on which performance by Dr. Gerlach is completed.  The fair value of each Warrant Share is estimated at the end of each fiscal quarter during which Dr. Gerlach renders services using the Black-Scholes option pricing model.  The fair value of each Warrant Share was approximately $0.47 as of September 30, 2013.  Assumptions regarding volatility, expected term, dividend yield and risk-free interest rate are required for the Black-Scholes model and are as follows:
	Weighted average risk-free interest rate	1.7	%
	Expected life in years	6
	Weighted average expected volatility	99	%
	Expected dividend yield	0

Common_Stock_Options

Common Stock Options	9 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
Note 6. Common Stock Options	'
	Approval of the 2013 Long-Term Incentive Plan
	On June 20, 2013, the Board of Directors (the “Board”) adopted, subject to receiving shareholder approval, the 2013 Long-Term Incentive Plan (the “Incentive Plan”). The Incentive Plan provides for the issuance of stock options of up to 20,000,000 shares (subject to adjustment) of the Company’s common stock to officers, directors, key employees and consultants of the Company. Options granted to employees under the Incentive Plan, including directors and officers who are employees, may be incentive stock options or non-qualified stock options; options granted to others under the Incentive Plan are limited to non-qualified stock options.
	The Incentive Plan is administered by the Board or a committee designated by the Board. Subject to the provisions of the Incentive Plan, the Board has the authority to determine the officers, employees and consultants to whom options will be granted, the number of shares covered by each option, vesting rights and the terms and conditions of each option that is granted to them; however, no person may be granted in any of the Company’s fiscal year, options to purchase more than 2,000,000 shares under the Incentive Plan, and the aggregate fair market value (determined at the time the option is granted) of the shares with respect to which incentive stock options are exercisable for the first time by an optionee during any calendar year cannot exceed $100,000. Options granted pursuant to the Incentive Plan are exercisable no later than ten years after the date of grant.
	The exercise price per share of common stock for options granted under the Incentive Plan will be the fair market value of the Company’s common stock on the date of grant, using the closing price of the Company’s common stock on the last trading day prior to the date of grant, except for incentive stock options granted to a holder of ten percent or more of the Company’s common stock, for whom the exercise price per share will not be less than 110% of the fair market value. No option can be granted under the Incentive Plan after June 20, 2023.
	As of September 30, 2013, there were 19,960,000 shares available for grant.
	Stock Option Activity
	The following table summarizes stock option activity for the three months ended September 30, 2013.
		Options			Weighted		Weighted		Aggregate
		Outstanding			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual Life (Years)
	Balance June 30, 2013		350,000		$	0.72			$	-
	Options granted		40,000		$	0.65
	Options forfeited		(350,000	)	$	0.72
	Options exercised		-			-
	Balance September 30, 2013		40,000		$	0.65		10	$	-
	Exercisable at September 30, 2013		20,000		$	0.65
	The fair value of each stock option is estimated at the date of grant using the Black-Scholes option pricing model. The estimated weighted-average fair value of stock options granted during the nine month period ended September 30, 2013 was approximately $0.41 per share. Assumptions regarding volatility, expected term, dividend yield and risk-free interest rate are required for the Black-Scholes model. The volatility assumption is based on the Company’s historical experience. The risk-free interest rate is based on a U.S. treasury note with a maturity similar to the option award’s expected life. The expected life represents the average period of time that options granted are expected to be outstanding. The assumptions for volatility, expected life, dividend yield and risk-free interest rate are presented in the table below:
	Weighted average risk-free interest rate		0.1	%
	Expected life in years	5.25
	Weighted average expected volatility		79	%
	Expected dividend yield		0
	During the three and nine month periods ended September 30, 2013, stock-based compensation expense of $8,792 and $9,622, respectively, was recognized as general and administrative expenses. There were 20,000 stock options vested and 20,000 unvested, during three and nine months ended September 30, 2013.  There was no stock compensation expense recognized in 2012. As of September 30, 2013, the Company had $6,873 of total unrecognized compensation cost related to unvested stock options, which is expected to be recognized by September 30, 2014.
	The Company issues new shares when options are exercised.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2013
Commitments And Contingencies	'
Note 7. Commitments and Contingencies	'
	As part of the acquisition of the Fostung Property the Company will pay to Breakwater Resources Ltd. (i) a Production Bonus in the amount of CAD $500,000 within thirty (30) business days following the commencement of commercial production from the property and (ii) a 1% Net Smelter Return royalty.
	On June 27, 2012, the Company entered into an At-Will Executive Services Agreement (the “Bien Services Agreement”) with Ms. Janet Bien, pursuant to which Ms. Bien was to serve as the Company’s Chief Financial Officer. Pursuant to the Bien Services Agreement, Ms. Bien was to provide the Company with services consistent with that of a Chief Financial Officer on a part-time basis, for which she was to be paid a monthly fee of $2,400 and was to be reimbursed for any business related expenses. The Bien Services Agreement was terminable by either the Company or Ms. Bien upon written notice with or without cause. The Bien Services Agreement was terminated effective as of September 30, 2013.
	On February 15, 2013, the Company entered into an agreement with Kenneth Kirkland, Ph.D. (the “Kirkland AB Agreement”) pursuant to which Dr. Kirkland will serve as a member of the Company’s Advisory Board. The Kirkland AB Agreement provides for a monthly fee of $2,000 and may be terminated by either party with a five day notice. The Kirkland AB Agreement was terminated effective as of June 30, 2013.
	As part of the Company’s acquisition on July 12, 2013 of the Regeneration Technology, the Company agreed to pay Vector Asset Management, Inc. (“Vector”) a finder’s fee in the amount of $47,000 (the “Cash Fee”) within 60 days of the closing of the acquisition of the Regeneration Technology (the “Closing Date”). Vector may elect to receive the Cash Fee, or a portion thereof, by accepting a convertible promissory note (the “Vector Note”) in the principal amount of any or all of the Cash Fee otherwise payable and bearing interest at the rate of 7% per annum, payable upon the earlier of December 14, 2014, or upon demand in the event that the Company shall have effected a financing or series of financings in excess of $1,000,000. The Vector Note will be convertible into shares of the Company’s common stock at a price equal to the average closing prices of the Company’s common stock for the 10 trading days prior to the Closing Date.  As of the date of this report, no convertible promissory note has been issued.
	On August 1, 2013, the Company engaged Vector to assist the Company with identifying subject matter experts in the medical device and biotechnology industries and to assist the Company with its ongoing research, development and eventual commercialization of its Regeneration Technology (collectively, the “Services”). In consideration of the Services, the Company will pay Vector a monthly consulting fee of Five Thousand Dollars ($5,000). The consulting agreement with Vector continues until December 31, 2014, unless earlier terminated by either party upon five (5) days prior written notice.  Vector is not considered a related party.
	See also Note 8. Related Party Transactions.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2013
Related Party Transactions	'
Note 8. Related Party Transactions	'
	Effective as of June 19, 2012, Mr. Joseph Sierchio, a member of the Company’s Board, was appointed as its Acting Interim President and Chief Executive Officer; and effective as of June 27, 2012, Ms. Janet Bien was appointed as the Company’s Chief Financial Officer.
	On June 20, 2013, Mr. Joseph Sierchio, resigned as the Acting Interim President and Chief Executive Officer and remains a director; Ms. Rhonda B. Rosen was appointed to serve as the President and Chief Executive Officer and a member of the Board and entered into an employment agreement for a two year term (the “Rosen Employment Agreement”), subject to the earlier termination provisions contained therein. Pursuant to the terms of the Rosen Employment Agreement, Ms. Rosen is paid an annual salary of $120,000. In addition to Ms. Rosen’s salary, she is eligible to receive a cash bonus to be determined by our Board, in their sole discretion. The Rosen Employment Agreement also provides Ms. Rosen with a monthly stipend of no more than $1,500 to cover medical insurance premiums until such time as the Company can make available an alternative medical insurance plan.
	On July 29, 2013, the Board appointed Dr. Kenneth Kirkland to serve as a member of the Board effective August 1, 2013. Prior to this appointment, Dr. Kirkland resigned from the Company’s Advisory Board. See “Note 7. Commitments and Contingencies.”
	As compensation for their service on the Board, Dr. Kirkland and Mr. Sierchio will receive an annual retainer of $6,000, payable in equal quarterly installments in arrears and prorated for any partial quarters of service. Additionally, subject to their entering into a non-statutory stock option agreement with us, Dr. Kirkland and Mr. Sierchio were each issued incentive stock options to purchase up to 20,000 shares of our common stock at an exercise price of $0.65 per share, the closing price of the Company’s common stock as quoted on the OTC Markets Group Inc. QB tier (the “OTCQB”) on July 31, 2013, pursuant to the Incentive Plan. Subject to their continued service as a member of the Board, 10,000 of the option shares vest immediately and 10,000 of the option shares vest on the first anniversary of date of grant.
	Effective September 30, 2013, Ms. Bien resigned as the Company’s Chief Financial Officer. Effective September 30, 2013, Ms. Rosen resigned as President and Chief Executive Officer, the Rosen Employment Agreement was terminated and the Company entered into an At-Will Executive Services Agreement (the “Rosen Services Agreement”), pursuant to which Ms. Rosen will serve as the Company’s Chief Financial Officer. Pursuant to the Rosen Services Agreement, Ms. Rosen will provide the Company with services consistent with that of a Chief Financial Officer on a part-time basis, for which she will be paid a monthly fee of $2,400 and will be reimbursed for any business related expenses. The Rosen Services Agreement is terminable by either the Company or Ms. Rosen upon advance written notice. The incentive stock options to purchase up to 350,000 shares of the Company’s common stock at an exercise price of $0.72 per share, previously issued to Ms. Rosen, were forfeited effective September 30, 2013.
	Effective September 30, 2013, Mr. Sierchio resumed the position of Acting Interim President and Chief Executive Officer.
	For the three and nine month periods ended September 30, 2013, fees of $75,040 (2012: $43,298) and $105,432 (2012: $82,210), respectively, were paid or are due to officers and directors of the Company. Amounts included in accounts payable and due to related parties at September 30, 2013 were $74,562 (December 31, 2012: $9,638).

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2013
Subsequent Events	'
Note 9. Subsequent Events	'
	There were no subsequent events to disclose as of the issue date of this report.

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2013
Significant Accounting Policies Policies	'
Basis of Presentation and Principles of Accounting	'
	As the Company is devoting substantially all of its efforts to establishing a new business, and while planned principal operations have commenced, there has been no revenue generated from sales, license fees or royalties, and as such, the Company is considered a development stage company. Accordingly, the Company’s consolidated financial statements are presented in accordance with authoritative accounting guidance related to a development stage enterprise.
	The interim consolidated financial statements included herein have been prepared by the Company, without audit, in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) pursuant to Part 210 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations, although the Company believes that the disclosures included are adequate to make the information presented not misleading.
	In management’s opinion, the unaudited consolidated financial statements contained herein reflect all adjustments, consisting solely of normal recurring items, which are necessary for the fair presentation of our financial position, results of operations, and cash flows on a basis consistent with that of our prior audited consolidated financial statements. The Company has evaluated information about subsequent events that became available to us through the date the financial statements were issued. This information relates to events, transactions or changes in circumstances that would require us to adjust the amounts reported in the financial statements or to disclose information about those events, transactions or changes in circumstances. However, the results of operations for interim periods may not be indicative of results to be expected for the full fiscal year. Therefore, these financial statements should be read in conjunction with the Company’s audited consolidated financial statements including the notes thereto for the year ended December 31, 2012, which may be found under the Company’s profile on EDGAR.
	The accounting policies followed by the Company are set out in Note 2 to the audited consolidated financial statements for the year ended December 31, 2012 and have been consistently followed in the preparation of these interim consolidated financial statements.
Principles of Consolidation	'
	These interim consolidated financial statements have been prepared in accordance with US GAAP and include the accounts of the Company and its wholly owned subsidiaries, JAC and Fostung Resources, Limited (“Fostung”). All significant intercompany transactions and balances have been eliminated. JAC was incorporated under the laws of the State of Nevada on June 12, 2013. Fostung was incorporated on May 10, 2011, in Ontario Canada.
Applicable Accounting Guidance	'
	Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative non-governmental US GAAP as found in the Financial Accounting Standards Board’s Accounting Standards Codification.
Accounting Estimates	'
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined by future events, may differ from these estimates.
Cash and Cash Equivalents	'
	The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents at September 30, 2013 and December 31, 2012.
Research and Development Costs	'
	The Company intends to outsource its research and development efforts and expense related costs as incurred, including the cost of manufacturing product for testing, licensing fees and costs associated with planning and conducting clinical trials. The value ascribed to patents and other intellectual property acquired will be capitalized as it relates to particular research and development projects that may have alternative future uses.
Stock Options	'
	The Company measures all stock-based compensation awards using a fair value method on the date of grant and recognizes such expense in its consolidated financial statements over the requisite service period. The Company uses the Black-Scholes pricing model to determine the fair value of stock-based compensation awards on the date of grant. The Black-Scholes pricing model requires management to make assumptions regarding option lives, expected volatility, and risk free interest rates.
Income Taxes	'
	The Company recognizes income taxes on an accrual basis based on tax positions taken, or expected to be taken, in our tax returns.  A tax position is defined as a position in a previously filed tax return or a position expected to be taken in future tax filing that is reflected in measuring current or deferred income tax assets and liabilities.  Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities.  Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our financial statements or tax returns.  A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized.  No provision for income taxes was recorded during the periods presented because the Company had a net taxable loss.  Should they occur, our policy is to classify interest and penalties related to tax positions as interest expense.  Since our inception, no such interest or penalties have been incurred.
Discontinued Operations	'
	The assets and financial results of the Company’s oil and gas properties are being reported as discontinued operations as a result of the sale thereof in February 2013. Certain amounts reported in the prior periods presented have been reclassified to conform to the current period financial statement presentation. These reclassifications have no effect on previously reported net income (loss). See “Note 3. Discontinued Oil and Gas Operations” for a summary of the amounts reclassified for the periods presented herein.
Earnings (Loss) Per Share	'
	The Company presents both basic and diluted earnings per share (“EPS”) amounts. Basic EPS is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period presented. Diluted EPS amounts are based upon the weighted average number of common and common equivalent shares outstanding during the period presented. Potentially dilutive shares of common stock consisted of warrants to purchase shares of common stock (1,200,000 shares for 2013 and nil shares for 2012) and options to purchase shares of common stock (40,000 shares for 2013 and nil shares for 2012).  During the periods presented, potentially dilutive shares of common stock were not included in the computation of dilutive loss per share as to do so would be anti-dilutive.
Foreign Currency Translation	'
	Transactions and account balances originally stated in currencies other than the U.S. dollar have been translated into U.S. dollars as follows:
	·	Revenue and expense items are translated at the average exchange rate for the period in which they are incurred.
	·	Non-monetary assets and liabilities at the rate of exchange in effect on the dates the assets were acquired or the liabilities were incurred.
	·	Monetary assets and liabilities at the exchange rate at the balance sheet date.
	Exchange gains and losses are recorded in operations in the period in which they occur, except for exchange gains and losses related to translation of monetary assets and liabilities associated with mineral properties, which are deferred and included in reported value of the mineral properties.
Comprehensive Income (Loss)	'
	Comprehensive loss is comprised of net loss and foreign currency translation adjustments for the periods presented.
Related Party Transactions	'
	A related party is generally defined as (i) any person who holds 10% or more of the Company’s securities and their immediate families; (ii) the Company’s management; (iii) someone who directly or indirectly controls, is controlled by or is under common control with the Company; or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. See “Note 8. Related Party Transactions,” for further discussion.

Discontinued_Oil_and_Gas_Opera1

Discontinued Oil and Gas Operations (Tables)	9 Months Ended
	Sep. 30, 2013
Discontinued Oil And Gas Operations Tables	'
Assets and liabilities of discontinued operations	'
	Assets and liabilities of discontinued operations in the accompanying balance sheets consist of the following:
		30-Sep-13		31-Dec-12
	Assets
	Unproven Properties	$	-	$	537,501
	Depriciation and impairment		-		(513,374	)
	Oil and gas properties, net	$	-	$	24,127
	Liabilities
	Accounts payable	$	-	$	(12,932	)
	Asset retirement obligation		-		(57,532	)
		$	-	$	(70,464	)

Intangible_Assets_Intellectual1

Intangible Assets - Intellectual Property (Tables)	9 Months Ended
	Sep. 30, 2013
Intangible Assets - Intellectual Property	'
Intangible Assets - Intellectual Property	'
	Assumptions regarding volatility, expected term, dividend yield and risk-free interest rate are required for the Black-Scholes model and are as follows:
	Weighted average risk-free interest rate	1.7	%
	Expected life in years	6
	Weighted average expected volatility	99	%
	Expected dividend yield	0

Common_Stock_Options_Tables

Common Stock Options (Tables)	9 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
Stock Option Activity	'
	The following table summarizes stock option activity for the nine months ended September 30, 2013.
		Options			Weighted		Weighted		Aggregate
		Outstanding			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual Life (Years)
	Balance June 30, 2013		350,000		$	0.72			$	-
	Options granted		40,000		$	0.65
	Options forfeited		(350,000	)	$	0.72
	Options exercised		-			-
	Balance September 30, 2013		40,000		$	0.65		10	$	-
	Exercisable at September 30, 2013		20,000		$	0.65
The assumptions for volatility, expected life, dividend yield and risk-free interest rate	'
	The expected life represents the average period of time that options granted are expected to be outstanding. The assumptions for volatility, expected life, dividend yield and risk-free interest rate are presented in the table below:
	Weighted average risk-free interest rate		0.1	%
	Expected life in years	5.25
	Weighted average expected volatility		79	%
	Expected dividend yield		0

Organization_Nature_and_Contin1

Organization, Nature and Continuance of Operations (Details Narrative) (USD $)	Sep. 30, 2013
Organization Nature And Continuance Of Operations	'
Total Accumulated deficit	$4,456,504

Significant_Accounting_Policie2

Significant Accounting Policies (Details Narrative)	Sep. 30, 2013	Dec. 31, 2012
Significant Accounting Policies Details Narrative	'	'
Common stock consisted of warrants to purchase shares	1,200,000	0
Ccommon stock options to purchase shares	40,000	0

Discontinued_Oil_and_Gas_Opera2

Discontinued Oil and Gas Operations (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Accounts payable [Member]	'	'
Liabilities	'	($12,932)
Asset retirement obligation [Member]	'	'
Liabilities	'	-57,532
Total Liabilities [Member]	'	'
Liabilities	'	-70,464
Unproven Properties [Member]	'	'
Assets	'	537,501
Depreciation and impairment [Member]	'	'
Assets	'	-513,374
Oil And Gas Properties, Net [Member]	'	'
Assets	'	24,127
Accounts payable [Member]	'	'
Liabilities	'	'
Asset retirement obligation [Member]	'	'
Liabilities	'	'
Total Liabilities [Member]	'	'
Liabilities	'	'

Discontinued_Oil_and_Gas_Opera3

Discontinued Oil and Gas Operations (Details Narrative) (USD $)	3 Months Ended		7 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012
Discontinued Oil And Gas Operations	'	'	'	'	'
Disposal of oil and gas properties	'	'	'	$49,338	'
Revenues in discontinued operation	0	7,034	'	0	16,549
Net income in discontinued operation	$0	($424)	'	$49,338	($389)

Intangible_Assets_Intellectual2

Intangible Assets - Intellectual Property (Details)	9 Months Ended
	Sep. 30, 2013
Intangible Assets - Intellectual Property	'
Weighted average risk-free interest rate	1.70%
Expected life in years	'6 years
Weighted average expected volatility	99.00%
Expected dividend yield	0.00%

Intangible_Assets_Intellectual3

Intangible Assets - Intellectual Property (Details Narrative) (USD $)	9 Months Ended
	Sep. 30, 2013
Intangible Assets - Intellectual Property	'
Fair value of Warrant Share	$0.47

Common_Stock_Options_Details

Common Stock Options (Details) (USD $)	3 Months Ended
	Sep. 30, 2013
Options Outstanding	'
Outstanding, Beginning	350,000
Options granted	40,000
Options forfeited	-350,000
Options exercised	'
Outstanding, Ending	40,000
Exercisable	20,000
Weighted Average Exercise Price	'
Outstanding, Beginning	$0.72
Options granted	$0.65
Options forfeited	$0.72
Options exercised	'
Outstanding, Ending	$0.65
Exercisable	$0.65
Weighted Average Remaining Contractual Life (Years)	'
Outstanding, Beginning	'0 years
Outstanding, Ending	'10 years
Aggregate Intrinsic value	'
Outstanding, Beginning	'
Outstanding, Ending	'

Common_Stock_Options_Details_1

Common Stock Options (Details 1)	9 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
Weighted average risk-free interest rate	0.10%
Expected life in years	'5 years 3 months
Weighted Avg Expected volatiltiy	79.00%
Expected dividend yield	0.00%

Common_Stock_Options_Details_N

Common Stock Options (Details Narrative) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
Notes to Financial Statements	'	'
Shares available	19,650,000	19,650,000
Stock options granted	'	$0.41
Stock-based compensation administrative expense	$8,792	$9,622
Stock options unvested	20,000	20,000
Stock options vested	20,000	20,000
Unrecognized compensation cost	$6,873	$6,873

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013
			Management Fee [Member]	Officer [Member]	Officer [Member]	Non Officer Director [Member]	Non Officer Director [Member]
				Management Fee [Member]	Management Fee [Member]	Management Fee [Member]	Management Fee [Member]
Fees paid or due to related party	'	'	'	$75,040	$75,040	$105,432	$105,432
Accounts payable - related parties	$74,562	$9,638	$74,562	'	'	'	'